Dexcom's Over-the-Counter Continuous Glucose Monitoring Revolutionizes Diabetes Care

Monday, 26 August 2024, 04:36

Dexcom's over-the-counter continuous glucose sensors are transforming diabetes management. The new Stelo sensor, approved by the US health regulator, offers an accessible option for users wishing to monitor their glucose levels without a prescription. This innovative device is now available at a price of up to $99, marking a significant step in diabetes technology.
LivaRava_Technology_Default_1.png
Dexcom's Over-the-Counter Continuous Glucose Monitoring Revolutionizes Diabetes Care

Breakthrough in Diabetes Management

Dexcom has unveiled its latest innovation in diabetes technology—the Stelo continuous glucose monitor, now available over-the-counter in the U.S. This advancement allows consumers easier access to glucose monitoring without the need for a prescription.

Key Features of Stelo

  • FDA Approval: The sensor received clearance from the US health regulator, ensuring its safety and efficacy.
  • Cost-Effective: Priced at up to $99, Stelo presents a budget-friendly option.
  • Ease of Use: Designed for simplicity, it allows individuals to monitor their glucose levels effortlessly.

The Future of Diabetes Care

This launch signifies a pivotal change in how diabetes care is approached, empowering users with tools to manage their health more effectively. Expect more updates and innovations as Dexcom continues to lead in diabetes technology.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most reliable and up-to-date tech news. Stay informed and elevate your tech expertise effortlessly.

Subscribe